GENEVA, May 19 -- ZYLORION HEALTH INC. (202-6th Avenue SW, Suite 660Calgary, Alberta T2P 2R9) filed a patent application (PCT/US2024/055213) for "CO-ADMINISTRATION OF A CO-CRYSTAL OF PSILOCYBIN AND PSILOCIN WITH AN ATYPICAL ANTIPSYCHOTIC" on Nov 08, 2024. With publication no. WO/2025/101960, the details related to the patent application was published on May 15, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): SILVERSTONE, Peter (202-6th Avenue SW, Suite 660Calgary, Alberta T2P 2R9), LAPRAIRIE, Robert (c/o University of Saskatchewan3B36 - 104 Clinic PlaceSaskatoon, Saskatchewan S7N 5E5), KURRA...